title: Hypercoagulability in dogs: treatment.
abstract: Hypercoagulability is a state in which the hemostatic balance shifts toward excessive platelet activation and fibrin deposition, leading to thrombosis. Although a definitive diagnosis is often difficult to make, identifying patients at risk for thromboembolism is critical. By identifying these patients and understanding mechanisms that contribute to hypercoagulability, clinicians can select protocols that aid in thrombus prevention. Several therapeutic options exist, including antiplatelet, anticoagulant, and fibrinolytic drugs.
authors.forename: Dianne
authors.initials: D
authors.lastname: Kitrell
authors.forename: Larry
authors.initials: L
authors.lastname: Berkwitt
mesh_terms: D000818:Animals; D000925:Anticoagulants / Q000627:therapeutic use*; D004283:Dog Diseases / Q000188:drug therapy*; D004285:Dogs; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D019851:Thrombophilia / Q000188:drug therapy / Q000662:veterinary*; D016896:Treatment Outcome
chemical_list: D000925:Anticoagulants; D005343:Fibrinolytic Agents; D010975:Platelet Aggregation Inhibitors